Skip to main content
Open access
LETTERS TO THE EDITOR
Published Online: 26 February 2021

Black Box Warning Did Not Cause Increased Suicides

Publication: Psychiatric Research and Clinical Practice
In their article “Increases in suicide deaths among adolescents and young adults following US Food and Drug Administration antidepressant boxed warnings and declines in depression care” Lu et al. claimed that the suicidality Black Box Warning for antidepressants led to decreased treatment of depression, which caused a high number of excess suicides among adolescents and young adults in the United States (1).
Treatment of youth depression has actually not substantially decreased since the Black Box warning. Lu et al. found a decrease in antidepressant treatment of less than one percentage point among children and adolescents from 2000 to 2010 (2). Kafali et al. found that antidepressant prescription rates for youth returned to prewarning levels by 2009 (3). Among parents who indicated that their child had severe impairment on the Columbia Impairment Scale, there was no decrease in antidepressant prescriptions after the warning. Valluri et al. examined changes in antidepressant prescribing from 2004 to 2006 and found that adolescents with major depressive disorder did not experience a decrease in antidepressant treatment (4). Rather, decreases in antidepressant prescribing occurred among those with major depression not otherwise specified and dysthymia diagnoses.
Furthermore, Plöderl & Hengartner found a strong correlation between increased self‐reported antidepressant use and more self‐reported suicide attempts between 2004 and 2016 among adolescents (5). However, population‐wide associations between antidepressant prescribing and suicides cannot establish causality, due to an inability to control for extraneous variables which may influence suicide rates (6). There are better ways to demonstrate whether a drug causes suicidality, such as the placebo‐controlled trials that originally led to the FDA warning (7). In sum, the evidence does not support Lu et al.‘s (1) contention that regulatory warnings led to decreased treatment, which then led to increased suicides.

Footnotes

Glen I. Spielmans has holdings in Vanguard Healthcare, a mutual fund that invests heavily in pharmaceutical firms.
The article that is the subject of this Letter is available here: https://doi.org/10.1176/appi.prcp.20200012. The Response to this Letter is available here: https://doi.org/10.1176/appi.prcp.20200039.

REFERENCES

1.
Lu CY, Penfold RB, Wallace J, et al. Increases in suicide deaths among adolescents and young adults following US Food and Drug Administration antidepressant boxed warnings and declines in depression care. Psychiatr Res Clin Pract 2020;2:43–52
2.
Lu CY, Zhang F, Lakoma MD, et al. Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi‐experimental study. BMJ 2014;348:g3596
3.
Kafali N, Progovac A, Hou SS‐Y, et al. Long‐run trends in antidepressant use among youths after the FDA Black Box warning. Psychiatr Serv 2018;69:389–395
4.
Valluri S, Zito JM, Safer DJ, et al. Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new‐onset depression. Med Care 2010;48:947–954
5.
Plöderl M, Hengartner MP. Antidepressant prescription rates and suicide attempt rates from 2004 to 2016 in a nationally representative sample of adolescents in the USA. Epidemiol Psychiatr Sci 2019;28:589–591
6.
Spielmans GI, Spence‐Sing T, Parry P. Duty to warn: antidepressant black box suicidality warning is empirically justified. Front Psychiatry 2020;11:18
7.
Hammad TA. Relationship between psychotropic drugs and pediatric suicidality. Food and Drug Administration. 2004. https://www.dropbox.com/s/gto5w4qcumk9hic/2004%20FDA%20Hammad.pdf?dl=0

Information & Authors

Information

Published In

Go to Psychiatric Research and Clinical Practice
Psychiatric Research and Clinical Practice
Pages: 97

History

Accepted: 3 January 2020
Received: 15 November 2020
Published online: 26 February 2021
Published in print: Summer 2021

Authors

Details

Glen I. Spielmans, Ph.D.
Department of Psychology, Metropolitan State University, Saint Paul, Minnesota (G. I. Spielmans); School of Clinical Medicine – Children's Health Queensland Unit, University of Queensland, Brisbane (P. Parry); College of Medicine and Public Health, Flinders University, Adelaide, South Australia (P. Parry)
Peter Parry, MBBS, FRANZCP
Department of Psychology, Metropolitan State University, Saint Paul, Minnesota (G. I. Spielmans); School of Clinical Medicine – Children's Health Queensland Unit, University of Queensland, Brisbane (P. Parry); College of Medicine and Public Health, Flinders University, Adelaide, South Australia (P. Parry)

Notes

Send correspondence to Dr. Spielmans ([email protected])

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share